Publication Name	World Journal of Virology
Manuscript ID	65931
Country	Spain

Received	2021-03-17 22:35
Peer-Review Started	2021-03-17 22:41
To Make the First Decision
Return for Revision	2021-05-05 21:35
Revised	2021-05-12 12:22
Second Decision	2021-08-09 02:29
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-08-09 06:03
Articles in Press	2021-08-09 06:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-09-03 13:35
Publish the Manuscript Online	2021-09-16 10:35

ISSN	2220-3249 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Respiratory System
Manuscript Type	Evidence Review
Article Title	Scientific evidence in the COVID-19 treatment: A comprehensive review
Manuscript Source	Invited Manuscript
All Author List	Gorane Iturricastillo, Elena Ávalos Pérez-Urría, Felipe Couñago and Pedro Landete
Funding Agency and Grant Number
Corresponding Author	Gorane Iturricastillo, MD, Doctor, Doctor, Department of Pulmonology, Hospital Universitario de La Princesa, Calle Diego de Leon 62, Madrid 28006, Spain. iturricastillo.gorane@gmail.com
Key Words	COVID-19; SARS-CoV-2; Treatment; Viral phase; Inflammatory phase
Core Tip	Severe acute respiratory syndrome coronavirus-2 is responsible for the unknown pneumonia that appeared in Wuhan, China, in December 2019. Lots of known drugs have been proved for coronavirus disease 2019. Corticosteroids demonstrated reduction of 28-d mortality in patients who needed oxygen and remdesivir proved to be effective reducing recovery time. Other drugs need more evaluation before establishing their effectiveness.
Publish Date	2021-09-16 10:35
Citation	Iturricastillo G, Ávalos Pérez-Urría E, Couñago F, Landete P. Scientific evidence in the COVID-19 treatment: A comprehensive review. World J Virol 2021; 10(5): 217-228
URL	https://www.wjgnet.com/2220-3249/full/v10/i5/217.htm
DOI	https://dx.doi.org/10.5501/wjv.v10.i5.217

Full Article (PDF)	WJV-10-217.pdf
Full Article (Word)	WJV-10-217.docx
Manuscript File	65931_Auto_Edited-JPY.docx
Answering Reviewers	65931-Answering reviewers.pdf
Audio Core Tip	65931-Audio core tip.ogg
Conflict-of-Interest Disclosure Form	65931-Conflict-of-interest statement.pdf
Copyright License Agreement	65931-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	65931-Language certificate.pdf
Peer-review Report	65931-Peer-review(s).pdf
Scientific Misconduct Check	65931-Scientific misconduct check.pdf
Scientific Editor Work List	65931-Scientific editor work list.pdf
CrossCheck Report	65931-CrossCheck report.pdf